Hepatocellular Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
Condition: Hepatocellular Carcinoma Intervention: Drug: Sorafenib Tablets Sponsors: Damanhour University; Mransoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials

Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors
Condition: Hepatocellular Carcinoma Intervention: Drug: Anlotinib and TQB2450 Sponsors: Shanghai Zhongshan Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials

Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction
Conditions: Post-hepatectomy Liver Failure; Hepatocellular Carcinoma; Artificial Intelligence Interventions: Other: The explanation of deep learning framework (VAE-MLP) , including counterfactual explanations and layerwise relevance propagation; Other: The model prediction; Other: The model prediction and the explanation of deep learning framework (VAE-MLP) , including counterfactual explanati ons and layerwise relevance propagation Sponsors: Maastricht University; First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials

Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study
Condition: HCC Intervention: Drug: TACE Sponsor: Zhongda Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma Intervention: Procedure: E-TACE Sponsor: Xuhua Duan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials